These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 6795756

  • 1. Stimulation of coronary vascular prostacyclin and inhibition of human platelet thromboxane A2 after low-dose nitroglycerin.
    Schrör K, Grodzinska L, Darius H.
    Thromb Res; ; 23(1-2):59-67. PubMed ID: 6795756
    [No Abstract] [Full Text] [Related]

  • 2. EG-626: not a thromboxane A2 antagonist, but a PGI2 potentiator in platelet aggregation.
    Tanaka K, Harada Y, Katori M.
    Prostaglandins; 1979 Feb; 17(2):235-7. PubMed ID: 375319
    [No Abstract] [Full Text] [Related]

  • 3. Studies of the influence of nitroglycerin on the synthesis of prostaglandins and thromboxane A2 and on platelet aggregation.
    Rettkowski W, Pönicke K, Block HU, Giessler C, Dunemann A, Zehl U, Förster W.
    Arzneimittelforschung; 1982 Feb; 32(3):194-200. PubMed ID: 6805480
    [Abstract] [Full Text] [Related]

  • 4. [Thromboxane A2 antagonist, prostacyclin (PGI2)--its in vivo secretion and action mechanism].
    Okuma M.
    Nihon Rinsho; 1978 Dec 10; 36(12):3830-5. PubMed ID: 372621
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prostacyclin, thromboxane A2 interactions in haemostasis and thrombosis.
    Moncada S, Amezcua JL.
    Haemostasis; 1979 Dec 10; 8(3-5):252-65. PubMed ID: 389758
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB, Araki H, Lefer AM.
    Circulation; 1980 Dec 10; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Potentiation by dazoxiben, a thromboxane synthetase inhibitor, of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin.
    Bertele V, De Gaetano G.
    Eur J Pharmacol; 1982 Dec 03; 85(3-4):331-3. PubMed ID: 6295787
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prostacyclin and thromboxane A2 formation in response to adrenergic stimulation in humans: a mechanism for local control of vascular response to sympathetic activation?
    Serneri GG, Masotti G, Gensini GF, Poggesi L, Abbate R, Mannelli M.
    Cardiovasc Res; 1981 May 03; 15(5):287-95. PubMed ID: 7028264
    [No Abstract] [Full Text] [Related]

  • 18. Prostaglandin response to intravenous nitroglycerin.
    Nugent WC, Nieminen MT, Liapis CD, Watkins WD, Kong DL, Peterson MB, Philbin DM, Levine FH.
    J Surg Res; 1982 Sep 03; 33(3):225-32. PubMed ID: 6810023
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of prostacyclin and platelet thromboxane A2 by aspirin.
    N Engl J Med; 1981 May 07; 304(19):1173-5. PubMed ID: 7012620
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacological interactions between prostacyclin and thromboxanes.
    Whittle BJ, Moncada S.
    Br Med Bull; 1983 Jul 07; 39(3):232-8. PubMed ID: 6313114
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.